Piramal Healthcare buys 5.5% more stake in Vodafone India

Pharma major Piramal Healthcare has agreed to acquire additional 5.5% stake in cellular services operator Vodafone India for Rs 3,007 crore in cash. The stake will be acquired from ETHL Communications Holdings (Essar), and post the stake buy Piramal will hold about 11% in Vodafone India (VIL).
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
Real-time Stock quotes, portfolio, LIVE TV and more.
GeStepAhead SME Special
moneycontrol.com

Home » News » Business

Feb 06, 2012, 09.04 AM | Source: Moneycontrol.com

Piramal Healthcare buys 5.5% more stake in Vodafone India

Pharma major Piramal Healthcare has agreed to acquire additional 5.5% stake in cellular services operator Vodafone India for Rs 3,007 crore in cash. The stake will be acquired from ETHL Communications Holdings (Essar), and post the stake buy Piramal will hold about 11% in Vodafone India (VIL).

Like this story, share it with millions of investors on M3

Piramal Healthcare buys 5.5% more stake in Vodafone India

Pharma major Piramal Healthcare has agreed to acquire additional 5.5% stake in cellular services operator Vodafone India for Rs 3,007 crore in cash. The stake will be acquired from ETHL Communications Holdings (Essar), and post the stake buy Piramal will hold about 11% in Vodafone India (VIL).

Post Your Comments

Share Cancel

Piramal Healthcare buys 5.5% more stake in Vodafone India
Moneycontrol Bureau

Pharma major Piramal Healthcare has agreed to acquire additional 5.5% stake in cellular services operator Vodafone India for Rs 3,007 crore in cash. The stake will be acquired from ETHL Communications Holdings (Essar), and post the stake buy Piramal will hold about 11% in Vodafone India (VIL).

"The transaction follows the settlement between Vodafone and Essar over the sale of Essar's approximately 33% stake in VIL, announced in July 2011 and the purchase by Piramal of approximately 5.5% of the issued share capital of VIL from Essar in August 2011," it said on Saturday.

The deal contemplates various options for Piramal to exit VIL in future, including through a potential public share sale by VIL and by selling its stake back to Vodafone.

Piramal sold its formulations business to US-based Abbott in 2010 and has been looking to invest outside the pharma space. It recently announced its foray in the financial services segment. It has also entered the real estate sector with the acquisition of IndiaReit Fund Advisors and IndiaReit Investment Managers.

Piramal Healthcare shares closed up 4.5% at Rs 437.80 on NSE on Friday.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Piramal Healthcare buys 5.5% more stake in Vodafone India

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login